GlassScriptPhysician profile
Nebojsa Markovic
NPI 1376029769
$5,234.01
in general payments reported to CMS, 2019-2025
12 companies · $4,277 in 2025
The $4,277 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $42.99 · 2023: $103 · 2024: $811 · 2025: $4,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,301 · Travel and Lodging: $1,490 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,300.75 |
| Travel and Lodging | $1,490.28 |
| Education | $399.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,985.20 | 2024-2025 | Farapulse, Lux-Dx Insertable Cardiac Monitor, Finishing Wire Supportrak |
| Biosense Webster, INC. | $1,519.32 | 2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro |
| Biotronik INC. | $673.05 | 2024-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Medtronic, INC. | $419.68 | 2024-2025 | Micra, Pulseselect |
| Novartis Pharmaceuticals Corporation | $158.07 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.66 | 2022-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $111.81 | 2023-2024 | Farxiga, Andexxa |
| Philips North America LLC | $108.16 | 2025 | Igt Devices Undivided |
| Amgen INC. | $44.76 | 2024 | Repatha |
| Kiniksa Pharmaceuticals International, Plc | $30.13 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $18.31 | 2024 | |
| Kestra Medical Technology Services, INC. | $14.86 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nebojsa Markovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.